RCKT Rocket Corp: Accounting Value per Share

Graphic logo of Rocket Pharmaceuticals (RCKT)

Rocket Pharmaceuticals (RCKT) aims to become a leading player in the therapy of rare blood and heart pathologies by utilizing innovative vectors for one-time patient cures. Stable demand supports the business, although geopolitical tensions may complicate equipment logistics and patent protection. This market valuation chart for the company with a value of 3.35 complements data on the production model, where delegating raw material procurement to nano-factories eliminates operational disruptions.

Rocket Pharmaceuticals Inc (RCKT) Equity per Share: for the period 07/04/2022 - 10/27/2026

rocketpharma.com - analytical breakdowns and key metrics (RCKT)

- price and consensus price forecast:
Price Chart Rocket Pharmaceuticals Inc|RCKT - Analyst Consensus Forecast
- market capitalization data:
Market Valuation Rocket Pharmaceuticals, Inc.|RCKT - Aggregate Business Value
- book capitalization data:
Book Value per Share Rocket Pharmaceuticals|RCKT - Accounting Capitalization|Market Value to Book Value Ratio rocketpharma.com|RCKT - Total Business Assets
- debt and liquidity data:
Total Debt to Capital Rocket Pharmaceuticals|RCKT - Long-Term Debt to Capital|Short-Term Debt to Equity Rocket Pharmaceuticals, Inc.|RCKT - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Rocket Pharmaceuticals, Inc.
Fundamental company valuation:Rocket Pharmaceuticals Inc, RCKT
Manufactured products of Rocket Pharmaceuticals, Inc.

When screening business quality, an investor evaluates net assets, which serve as a guarantee of the enterprise's financial stability. The book value per share metric calculates the difference between all assets and liabilities per share, which for Rocket Pharmaceuticals (RCKT) confirms the capitalization of patents and resources for the launch of gene therapy, reflecting a real margin of safety in the dynamics of this book value per share metric.

Competitors of Rocket Pharmaceuticals (RCKT)

Tempus AI, Inc. - Net Assets per Single Share|Qiagen Corp (QGEN) - Book Value per Share|IONS - Accounting Value per Share|repligen.com (RGEN) - Book Price of a Share|Book Value per Share Avidity Biosciences, Inc. (RNA)|Equity per Share CRSP|Net Assets per Single Share Sema4 WGS|Equity per Share Ultragenyx Corp (RARE)|Book Value per Share BEAM (Beam Therapeutics Inc.)|sarepta.com - Book Value per Share|Net Assets per Single Share Twist Bioscience, Inc. (TWST)|TXG: Accounting Value of a Share|Net Assets per Single Share NTLA|Stoke Corp (STOK) - Net Asset Value per Share|Book Value per Share BLFS|Accounting Value per Share WVE|Net Assets per Single Share MAZE|Book Value per Share Sionna Therapeutics, Inc. (SION)|PRME: Book Value per Share|TSHA - Net Asset Value per Share|Accounting Value per Share uniQure N.V. QURE|meiragtx.com (MGTX) - Book Price of a Share|Accounting Value per Share REGENXBIO RGNX|SLDB (Solid Biosciences Inc) - Accounting Value of a Share|Net Assets per Single Share Ocugen Corp OCGN|Share Book Value PacBio Corp|Benitec Biopharma Inc. (BNTC) - Book Value per Share|Accounting Value of a Share designtx.com (DSGN)|Book Value per Share FDMT (4D Molecular Therapeutics, Inc.)|Lexeo Therapeutics Inc. - Book Value per Share|Net Assets per Single Share Korro Bio, Inc (KRRO)|EDIT: Accounting Value of a Share|SLN (Silence Therapeutics) - Net Assets per Single Share|ProQR Therapeutics (PRQR) - Accounting Value per Share|CDXS (Codexis Inc) - Book Value per Share|Book Value per Share Sangamo Therapeutics Inc.|Book Value per Share NAUT (Nautilus Biotechnology)|Accounting Value per Share Metagenomi Therapeutics (MGX)|DTIL: Book Value per Share|GBIO - Net Asset Value per Share|Boundless Bio - Accounting Value per Share|Exicure, Inc. (XCUR) - Book Value per Share|IMNN - Accounting Value per Share|Phio Pharmaceuticals Corp. (PHIO) - Book Price of a Share|MBIO: Book Value per Share|Net Assets per Share TransCode|Book Value per Share BNGO (Bionano Genomics, Inc.)|Accounting Value per Share Applied DNA Sciences Inc (APDN)|Book Value per Share BLUE (Bluebird Bio)|ImmunoPrecise Antibodies Ltd - Book Value per Share|OMGA - Net Assets per Single Share|OMIC: Net Assets per Single Share|Regulus Therapeutics Inc. - Net Assets per Single Share|SYRS (Syros Pharmaceuticals Inc.) - Net Assets per Share|TBIO - Net Assets per Single Share|Accounting Value of a Share TRACON Pharmaceuticals, Inc|Book Value per Share UBX (Unity Biotechnology)